23 participants
A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-20
- Start Date:
- 2011-01-10
- Completion:
- 2011-11-04
Conditions
- Advanced Hepatocellular Carcinoma (HCC)
Interventions
- DRUG
No Results Yet